Search

A protein in the body that protects against viruses can also cause cancer-related mutations.

… Wednesday, July 20, 2022 The body deploys many weapons to defend against internal and external threats. One tactic used by cells involves a group of proteins called APOBEC3 enzymes. These enzymes can disable viruses by disrupting the invaders’ genetic material. They also protect against certain genetic

Now in its 14th year, Cycle for Survival has raised more than $260 million for research on rare cancers.

… Wednesday, April 1, 2020 By Jim Stallard “Thanks to MSK and Cycle for Survival’s mission, I get to rewrite my story,” says Barbie Cervoni, one of thousands of participants who rode this year to raise money for rare cancer research at Memorial Sloan Kettering. Diagnosed with thymoma 12 years ago, Barbie

Memorial Sloan Kettering plastic and reconstructive surgeon Michelle Coriddi describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.

… Friday, October 13, 2023 Summary Women undergoing mastectomy as part of treatment for breast cancer not only have to cope with a cancer diagnosis and treatment but the decision of whether to have breast reconstructive surgery. Both options — implant surgery and flap surgery (in which the surgeon uses

Memorial Sloan Kettering Cancer Center (MSK) today announced it has received a new grant from the National Cancer institute (NCI), part of the National Institutes of Health, under the umbrella of the Cancer Moonshot, to create the MATCHES (Making Telehealth Delivery of Cancer Care at Home Effective and Safe) Telehealth Research Center at MSK, a first of its kind.

… Thursday, August 18, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced it has received a new grant from the National Cancer institute (NCI), part of the National Institutes of Health, under the umbrella of the Cancer Moonshot, to create the MATCHES (Making Telehealth Delivery of Cancer

A new project called the BRCA Exchange is sharing data about BRCA mutations and what they actually mean for cancer risk.

… Monday, February 11, 2019 Summary Clinical genetics experts from MSK and other institutions have launched the BRCA Exchange. This online database shares information about individual BRCA mutations and how they might increase cancer risk. Many people have heard that mutations in the genes BRCA1 and BRCA2

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.

… Sunday, December 7, 2014 A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial. The study, led by Eytan M. Stein, MD , a medical oncologist at Memorial Sloan Kettering Cancer Center, was presented today

Researchers at MSK have been at the forefront of developing new treatments for advanced melanoma for many years. Learn more about the latest therapies.

… Monday, July 8, 2024 In recent years, advanced melanoma (a type of skin cancer) has been transformed from a disease that was almost always fatal to one that often can be brought under control for years, or even cured. Thanks to new drugs, people with advanced disease have a five-year survival rate of

Learn from neurosurgeon Viviane Tabar about the standard treatment for glioblastoma, which involves surgery, chemotherapy, and radiation.

… Saturday, August 25, 2018 Summary The passing of Senator John McCain has focused attention on the aggressive brain cancer called glioblastoma. Viviane Tabar, Chief of Neurosurgery, explains how the disease develops and how MSK treats people with glioblastoma and other brain cancers. Editor’s Note: This

State-of-the-art facility will be reduced by 76 feet while continuing to meet increasing demand for cancer care.

… Friday, May 30, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced an updated design for MSK’s forthcoming Kenneth C. Griffin Pavilion at MSK, which includes a reduction in the originally proposed height of the building by 76 feet. The newly-designed Griffin Pavilion, slated for construction

Learn about the latest advances in lung cancer treatment at MSK.

… Friday, November 15, 2024 Lung cancer is the second-most common cancer and remains the leading cause of cancer death in the United States. But a variety of new treatments, many of them developed or tested at Memorial Sloan Kettering Cancer Center (MSK), are helping to bring down the number of deaths.